LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 3.66 | 27.76 | 2 | 283 | 0.0070 | -0.5435 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 3.66 | 27.76 | 588 | 283 | 2.0709 | 1.4847 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 3.66 | 27.76 | 677 | 283 | 2.3844 | 1.5914 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 5.36 | 27.76 | 2 | 320 | 0.0062 | -0.5255 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 5.36 | 27.76 | 633 | 320 | 1.9759 | 1.4258 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 5.36 | 27.76 | 789 | 320 | 2.4629 | 1.5820 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.06 | 27.76 | 8 | 360 | 0.0222 | -0.2858 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.06 | 27.76 | 731 | 360 | 2.0306 | 1.4223 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.06 | 27.76 | 861 | 360 | 2.3917 | 1.5320 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.76 | 27.76 | 21 | 401 | 0.0524 | -0.0699 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.76 | 27.76 | 804 | 401 | 2.0043 | 1.3955 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.76 | 27.76 | 3 | 401 | 0.0075 | -0.4387 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.76 | 27.76 | 939 | 401 | 2.3408 | 1.4940 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.46 | 27.76 | 28 | 438 | 0.0638 | 0.0022 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.46 | 27.76 | 838 | 438 | 1.9104 | 1.3530 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.46 | 27.76 | 6 | 438 | 0.0137 | -0.3193 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.46 | 27.76 | 1015 | 438 | 2.3140 | 1.4690 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.17 | 27.76 | 38 | 489 | 0.0777 | 0.0788 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.17 | 27.76 | 899 | 489 | 1.8382 | 1.3169 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.17 | 27.76 | 7 | 489 | 0.0143 | -0.2831 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.17 | 27.76 | 1064 | 489 | 2.1756 | 1.4132 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 13.87 | 27.76 | 43 | 604 | 0.0711 | 0.1035 | MN20160318_Q01 | J22 |